Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer
Clinical trial NCT02109341 · COMPLETED
Trial details
- NCT number
- NCT02109341
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2015-12-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.